A New York jury found for C.R. Bard in an antitrust case brought by competitor AngioDynamics, who said that the way Bard packaged its catheter tip location systems preloaded into central lines was anti-competitive.
Becton, Dickinson and Company subsidiary C.R. Bard’s approach to marketing its central catheter systems does not violate antitrust law, a New York federal jury concluded earlier this month in a case brought by competitor AngioDynamics, Inc..
The jury in the US District Court for the Northern District of New York found that AngioDynamics had failed to...
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
The last steps are taking place leading to the launch of the EU’s medical device database, EUDAMED.
CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.
